Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
When switching from tirzepatide to retatrutide makes sense Several scenarios might prompt a researcher to consider the transition: Weight loss has plateaued on tirzepatide
galcanezumab/Emgality by Eli Lilly
40% of that category said they expect to spend at least $500
New insights into Beta-cell GLP-1 receptor and cAMP signaling
Epicardial adipose tissue and cardiovascular dysfunction Frontiers in Cardiovascular Medicine, January 2026
US$ 20.18
US$ 26.48
US$ 29.03
US$ 24.47
US$ 21.10
US$ 29.43
US$ 29.75
US$ 28.92
